The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 06, 2015
Filed:
Oct. 06, 2011
Robert G. Aslanian, Rockaway, NJ (US);
Christopher W. Boyce, Flemington, NJ (US);
Robert D. Mazzola, Jr., Stewartsville, NJ (US);
Brian A. Mckittrick, New Vernon, NJ (US);
Kevin D. Mccormick, Basking Ridge, NJ (US);
Anandan Palani, Bridgewater, NJ (US);
Jun Qin, Somerset, NJ (US);
Haiqun Tang, Belle Mead, NJ (US);
Dong Xiao, Warren, NJ (US);
Younong Yu, East Brunswick, NJ (US);
John P. Caldwell, Ringwood, NJ (US);
Elizabeth Helen Kelley, Lynnfield, MA (US);
Hongjun Zhang, Newton, MA (US);
Phieng Siliphaivanh, Newton, MA (US);
Rachel N. Maccoss, Oxford, GB;
Joey L. Methot, Westwood, MA (US);
Jolicia Polivina Gauuan, Schenectady, NY (US);
Qin Jiang, Latham, NY (US);
Andrew J. Leyhane, Latham, NY (US);
Purakkattle Johny Biju, Piscataway, NJ (US);
LI Dong, Lawrenceville, NJ (US);
Xianhai Huang, Warren, NJ (US);
Ning Shao, Watchung, NJ (US);
Wei Zhou, Scotch Plains, NJ (US);
Pawan K. Dhondi, Elizabeth, NJ (US);
Ashwin U. Rao, Morganville, NJ (US);
Robert G. Aslanian, Rockaway, NJ (US);
Christopher W. Boyce, Flemington, NJ (US);
Robert D. Mazzola, Jr., Stewartsville, NJ (US);
Brian A. McKittrick, New Vernon, NJ (US);
Kevin D. McCormick, Basking Ridge, NJ (US);
Anandan Palani, Bridgewater, NJ (US);
Jun Qin, Somerset, NJ (US);
Haiqun Tang, Belle Mead, NJ (US);
Dong Xiao, Warren, NJ (US);
Younong Yu, East Brunswick, NJ (US);
John P. Caldwell, Ringwood, NJ (US);
Elizabeth Helen Kelley, Lynnfield, MA (US);
Hongjun Zhang, Newton, MA (US);
Phieng Siliphaivanh, Newton, MA (US);
Rachel N. MacCoss, Oxford, GB;
Joey L. Methot, Westwood, MA (US);
Jolicia Polivina Gauuan, Schenectady, NY (US);
Qin Jiang, Latham, NY (US);
Andrew J. Leyhane, Latham, NY (US);
Purakkattle Johny Biju, Piscataway, NJ (US);
Li Dong, Lawrenceville, NJ (US);
Xianhai Huang, Warren, NJ (US);
Ning Shao, Watchung, NJ (US);
Wei Zhou, Scotch Plains, NJ (US);
Pawan K. Dhondi, Elizabeth, NJ (US);
Ashwin U. Rao, Morganville, NJ (US);
Merck Sharp & Dohme Corp., Rahway, NJ (US);
Abstract
This application provides for compounds of the formula Formula I or a pharmaceutically acceptable salt thereof, wherein the individual variables are defined herein, as well as processes to prepare these compounds, pharmaceutical compositions comprising the same and their use in treating disease state associated with the CRTHreceptor.